Past Events

History of previous events

Apitope to present at the 18th International Celiac Disease Symposium ICDS – Paris, France

Professor David Wraith Apitope’s co-founder and CSO will present as an invited speaker at the 18th International Celiac Disease Symposium ICDS. The conference is being held between 5th and 11th September at the Marriott Rive Gauche in Paris.

Details

Apitope to present at ECTRIMS 2019 Stockholm, Sweden

Professor David Wraith Apitope’s founder and CSO and Dr Lotta Jansson, Chief Research Officer are scheduled to attend ECTRIMS 2019. The conference is being held in Stockholm Sweden between 11th-13th September ECTRIMS 2019 at the Stockholmsmässan. Professor Wraith will present during Session 12 entitled ‘Immunopathogenesis and antigen specific therapies’ details of which are below: 13…

Details

Apitope to present at Immunity for Health 2019 – Hasselt, Belgium

Professor David Wraith Apitope’s co-founder and CSO will present as an invited speaker at Immunity for Health 2019. The conference theme is Therapeutic Vaccines & Immunotherapy and is being held University Hasselt, Belgium on 15th October 2019. 15 October 2019 Key Note Presentation: The Future of Immunotherapy: A 20-Year Perspective Time: 15:50 Presenter: David Wraith

Details

Apitope to present at American College of Toxicology and Council

Professor David Wraith Apitope’s co-founder and CSO will present as an invited speaker at the 40th Annual Meeting, 17-20 November, 2019, at the JW Marriott Desert Ridge in Phoenix, Arizona. Professor Wraith will present during Session 10 entitled ‘Immune Tolerance: State-of-the-Science and Preclinical and Clinical Safety Challenges in Drug Development’: 19 November 2019 Presentation: State-of-Science…

Details

Apitope’s Chief Executive Officer, Dr Hayley French will be attending the BIO 2019 conference to be held on 3-6 June 2019 in Philadelphia, PA

Apitope’s Chief Executive Officer, Dr Hayley French will be attending the BIO 2019 conference to be held on 3-6 June 2019 in Philadelphia, PA

Details

Apitope presents at 2nd Antigen-Specific Immune Tolerance Summit Boston MA 2019

HASSELT, Belgium, and CHEPSTOW, UK, 29 March 2019 – Apitope, a clinical stage biotech company developing potential first-in-class antigen-specific immunotherapies targeting autoimmune diseases, announces that Chief Research Officer Dr Lotta Jansson and Chief Scientific Officer Professor David Wraith attended and presented  at the  2nd Antigen-Specific Immune Tolerance Summit Boston MA 2019  conference held on 26…

Details